F_mbjzUCnrjkXsrs461D32YJD9CGWQoWwptvxTREeMo MIVACRON (mivacurium chloride)
flexibility-logo

MIVACRON® (mivacurium chloride) INJECTION IS EASY TO TITRATE TO INDIVIDUAL PATIENT REQUIREMENTS1,2

MIVACRON provides the flexibility of multiple bolus dosing options1

Recommended initial dosing regimen
dosing-children
adult
30sec
maintanance-mob

Maintenance dosing for additional neuromuscular blockade1

maintenance

     

  1. Range in clinical trials:  9-38 minutes at 0.15 mg/kg, 10-36 minutes at 0.2 mg/kg, 14-38 minutes at 0.25 mg/kg
  2. Time to 25% spontaneous recovery
  3. For shorter or longer durations of action, smaller or larger maintenance doses may be administered
  4. NOTE: In patients with clinically significant cardiovascular disease and in patients with any history suggesting a greater sensitivity to the release of histamine or other mediators, the initial dose of MIVACRON should be 0.15 mg/kg or less, administered over 60 seconds.
  5.  

Learn more about

titrating MIVACRON

to individual patient

requirements with

the MIVACRON

Dosing Card1,2

Click to download
efficacy for mobile

Safety Considerations1

It is recommended that a peripheral nerve stimulator be used during the administration of MIVACRON to monitor drug effect, determine the need for additional drug, and confirm recovery from neuromuscular block. MIVACRON has no known effect on consciousness, pain threshold, or cerebration.